1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS
2 EXECUTIVE SUMMARY
2.1 GLOBAL BLUE BIOTECHNOLOGY MARKET
3 GLOBAL BLUE BIOTECHNOLOGY MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL BLUE BIOTECHNOLOGY MARKET SNAPSHOT
4 GLOBAL BLUE BIOTECHNOLOGY MARKET OVERVIEW- BY PRODUCT TYPE
4.1 INTRODUCTION
4.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY  PRODUCT TYPE
4.1.1.1 PHARMA
4.1.1.2 BIOFUELS
4.1.1.3 FOOD
4.1.1.4 ENZYMES
4.1.1.5 BIOPOLYMERS
4.1.1.6 OTHERS
5 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY APPLICATION
5.1 INTRODUCTION
5.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY APPLICATION
5.1.1.1 VACCINE DEVELOPMENT
5.1.1.2 GENOMICS
5.1.1.3 DRUG FINDING
5.1.1.4 OTHERS
6 GLOBAL BLUE BIOTECHNOLOGY MARKET ANALYSIS AND FORECAST, BY END- USER
6.1 INTRODUCTION
6.1.1 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY END- USER
6.1.1.1 PHARMACEUTICAL COMPANIES
6.1.1.2 BIOTECHNOLOGY COMPANIES
6.1.1.3 RESEARCH ORGANIZATION
6.1.1.4 HEALTHCARE SECTOR
7 GLOBAL BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
7.1 INTRODUCTION
7.2 KEY TAKEWAYS
8 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
8.1 MARKET DYNAMICS
8.1.1 DRIVERS
8.1.2 RESTRAINTS
8.1.3 OPPORTUNITIES
8.2 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE
8.3 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY  APPLICATION
8.4 NORTH AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
8.5 U.S.
8.6 CANADA
8.7 MEXICO
9 EUROPE BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY  PRODUCT TYPE
9.3 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY  APPLICATION
9.4 EUROPE BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
9.5 U.K.
9.6 FRANCE
9.7 GERMANY
9.8 ITALY
9.9 SPAIN
9.10 REST OF EUROPE
10 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS
10.1.3 OPPORTUNITIES
10.2 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY  PRODUCT TYPE
10.3 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY  APPLICATION
10.4 ASIA PACIFIC BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
10.5 INDIA
10.6 CHINA
10.7 JAPAN
10.8 REST OF ASIA PACIFIC
11 MIDDLE EAST AND AFRICA (MEA) BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
11.1 MARKET DYNAMICS
11.1.1 DRIVERS
11.1.2 RESTRAINTS
11.1.3 OPPORTUNITIES
11.2 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY  PRODUCT TYPE
11.3 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY  APPLICATION
11.4 MEA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
11.5 SOUTH AFRICA
11.6 REST OF MIDDLE EAST AND AFRICA
12 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
12.1 MARKET DYNAMICS
12.1.1 DRIVERS
12.1.2 RESTRAINTS
12.1.3 OPPORTUNITIES
12.2 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY PRODUCT TYPE
12.3 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY APPLICATION
12.4 LATIN AMERICA BLUE BIOTECHNOLOGY MARKET ANALYSIS- BY END- USER
12.5 BRAZIL
12.6 REST OF LATIN AMERICA
13 COMPETATIVE LANDSCAPE
13.1 GLOBAL BLUE BIOTECHNOLOGY MARKET-COMPANY MARKET SHARE ANALYSIS
14 COMPANY PROFILES: (REVENUE,  PRODUCTS/BRAND OFFERINGS, COMPANY HIGHLIGHTS)
14.1 AKER BIOMARINE
14.2 CELLGEN BIOLOGICALS PVT LTD.
14.3 DONALD DANFORTH PLANT SCIENCE CENTER
14.4 GEOMARINE BIOTECHNOLOGIES
14.5 GLYCOMAR
14.6 MARINOVA
14.7 NURTURE AQUA TECHNOLOGY PVT.
14.8 NEW ENGLAND BIOLABS
14.9 PICES
14.10 PML APPLICATION LTD.
14.11 SEA RUN HOLDINGS, INC
14.12 SHELL MARINE PRODUCTS
14.13 SANOSIL BIOTECH
14.14 SAMUDRA BIOPHARMA PRIVATE LIMITED